2 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07342116 2023-04-01 2024-03-31 07342116 2024-03-31 07342116 2023-03-31 07342116 2022-04-01 2023-03-31 07342116 2023-03-31 07342116 2022-03-31 07342116 bus:Director1 2023-04-01 2024-03-31 07342116 core:WithinOneYear 2024-03-31 07342116 core:WithinOneYear 2023-03-31 07342116 core:AfterOneYear 2024-03-31 07342116 core:AfterOneYear 2023-03-31 07342116 bus:Micro-entities 2023-04-01 2024-03-31 07342116 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 07342116 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07342116 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07342116 bus:FullAccounts 2023-04-01 2024-03-31
Company registration number: 07342116
Prologics Europe Limited
Unaudited filleted financial statements
31 March 2024
Prologics Europe Limited
Contents
Directors report
Statement of financial position and notes to the financial statements
Prologics Europe Limited
Directors report
Year ended 31 March 2024
The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2024.
Directors
The directors who served the company during the year were as follows:
Mr N P Pinder
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 09 September 2024 and signed on behalf of the board by:
Mr N P Pinder
Director
Prologics Europe Limited
Statement of financial position
31 March 2024
2024 2023
£ £ £ £
Fixed assets - 137
_______ _______
Current assets 54,738 69,557
Prepayments and accrued income 2,875 2,875
_______ _______
57,613 72,432
Creditors: amounts falling due within one year ( 61,755) ( 68,601)
_______ _______
Net current (liabilities)/assets ( 4,142) 3,831
_______ _______
Total assets less current liabilities ( 4,142) 3,968
Creditors: amounts falling due after more than one year ( 31,200) ( 35,550)
Accruals and deferred income ( 1,350) ( 1,441)
_______ _______
Net liabilities ( 36,692) ( 33,023)
_______ _______
Capital and reserves ( 36,692) ( 33,023)
_______ _______
Notes to the financial statements
Prologics Europe Limited
Year ended 31 March 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 3 ).
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 09 September 2024 , and are signed on behalf of the board by:
Mr N P Pinder
Director
Company registration number: 07342116
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Unit 10, Firbank Court, Firbank Way, Leighton Buzzard, Beds, LU7 4YJ.